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The objective of this study is to design a drug delivery system (DDS) for the in vivo promotion of 
macrophage recruitment. As the drug, a water-insoluble agonist of sphingosine-1-phosphate type 1 
receptor (SEW2871) was selected. The SEW2871 (SEW) was water-solubilized by the micelle 
formation with gelatin grafted by L-lactic acid oligomer. The SEW-micelles were mixed with gelatin, 
followed by the dehydrothermal crosslinking of gelatin to obtain gelatin hydrogels incorporating 
SEW-micelles. SEW was released from the hydrogels incorporating SEW-micelles in vitro and in 
vivo. The SEW water-solubilized showed an activity of in vitro macrophage migration. When 
implanted into the back subcutis or the skin wound defect of mice, the hydrogel incorporating 
SEW-micelles promoted the macrophage migration toward the tissue around the implanted site to a 
significantly great extent compared with SEW-free hydrogel and that mixed with SEW-micelles. The 





Macrophage plays a critical role in inflammation process. If macrophage is depleted, the wound 
repair is often delayed [1, 2]. Macrophage deteriorates severe inflammation, while they properly 
suppress inflammation to induce tissue regeneration [3, 4]. It is, thus, recognized that the 
inflammatory condition is greatly influenced by the existence and phenotype of macrophage. The 
findings suggest that the existence and phenotype of macrophage modify the extent of inflammation 
which can regulate the process of tissue regeneration. It is conceivable that the enhanced recruitment 
of macrophage physiologically induces the inflammation, which starts the regeneration and repairing 
possess for injured or damaged tissues although the quality of inflammation greatly affects that of 
healing process. However, the healing process will not start up without the suitable induction of 
inflammation. As the first trial to induce the inflammation, it will be essential to design a technology 
for enhancement of in vivo macrophage recruitment. The objective of this study is to develop the 
technology of macrophage recruitment and evaluate the extent of recruitment enhancement.  
A “find me” signal is known to function as the chemoattractant for macrophage [5]. Apoptotic 
cells secrete the “find me” signal by which macrophage is recruited to the cells for their phagocytic 
exclusion. Sphingosin-1-phosphate (S1P) is one of “find me” signals [6]. However, mouse 
macrophage have three types of S1P receptors, S1PR1, S1PR2, and S1PR3[7-9]. When S1P binds to 
the S1PR1, macrophage migration is enhanced [8, 10]. Oppositely, when S1P binds to the S1PR2, 
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macrophage migration is suppressed. The SEW2871 (5-[4-Phenyl-5-(trifluoromethyl) 
thiophen-2-yl]-3-[3-(trifluoromethyl) phenyl] 1,2,4-oxadiazole, SEW) is a S1PR1-specific agonist 
that does not act on the S1PR2 [11]. The SEW is a good drug to induce the recruitment of 
macrophage [12, 13]. Moreover, it has the weaker potential of S1PR1 down-regulation than another 
agonist of FTY720-P [14]. However, considering the in vivo efficient usage of water-insoluble and 
low-molecular weight SEW, it is necessary to develop the pharmaceutical form of administration.  
Gelatin is a biodegradable material and has been extensively used for food, pharmaceutical, and 
medical purposes. The biosafety has been proven through their long practical applications. Gelatin is 
a denatured form of collagen which is the most abundant component of extracellular matrix in the 
body tissue. The material itself and the product degraded are both biocompatible. The material 
advantages of gelatin are the easiness of chemical modification and the commercial availability of 
materials with different physicochemical properties. We have prepared hydrogels with different 
biodegradabilities from gelatin or the derivatives and succeeded in augmenting the therapeutic 
activities of water-soluble drugs, such as growth factors [15, 16], chemokine [17], plasmid DNA [18], 
anti-tumor drug [19], and siRNA [20]. It is found, in addition, that the hydrogel can release a 
water-insoluble drug in the controlled fashion [21]. 
In this study, the biodegradable gelatin hydrogel was designed for the controlled release of 
water-insoluble SEW. A hydrophobic derivative of gelatin was prepared by grafting L-lactic acid 
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oligomer (LAo) to gelatin. SEW was water-solubilized by the micelles formation with the gelatin 
grafted by LAo (LAo-g-gelatin) (SEW-micelles). The SEW-micelles were mixed with gelatin, 
followed by the dehydrothermal crosslinking in different conditions to obtain gelatin hydrogels 
incorporating SEW–micelles. We examine the in vitro and in vivo release of SEW from the 
hydrogels incorporating SEW–micelles. When the hydrogel incorporating SEW-micelles were 
implanted into the back subcutis of mice, the macrophage recruitment into the implanted site was 




2. Materials and Methods 
2.1. Materials 
Gelatin with an isoelectric point (pI) of 5.0 (Mw = 100,000), prepared via an alkaline process of 
bovine bone (pI5 gelatin) or with a pI of 9.0 (Mw = 100,000), prepared via an acid process of pig 
skin (pI9 gelatin) and collagenase L were kindly supplied from Nitta Gelatin Co., Osaka, Japan. 
Disuccimidyl carbonate (DSC), 4-dimethylaminopyridine (DMAP), and other chemicals were 
purchased from Nacalai Tesque Inc., Kyoto, Japan. SEW was purchased from Cayman Chemical Co., 
Michigan. 
 
2.2. Synthesis of L-Lactic acid oligomers 
L-lactic acid oligomers (LAo) with different molecular weights were synthesized from L-lactide 
monomers by ring opening polymerization with a stannous octate catalyst and 1-dodecanol as an 
initiator [22]. Briefly, L-lactide (20 g, 138.8 mmole, Purac Biochemical BV, Gorinchem, 
Netherlands) was melted at 130 °C in a nitrogen atmosphere, followed by the addition of toluene 
(5.6 ml) containing 1-dodecanol (4.67 g, 24.6 mmole, 2.10 g, 11.0 mmole or 1.35 g, 7.1 mmole) and 
stannous octate (0.56 g, 1.38 mmole). After mixing for 4 hr at 130 °C, the reaction product was 
dissolved in chloroform and the solution was poured into ethanol for precipitation three times. After 
precipitation, the solution was freeze-dried. The number-averaged molecular weight of LAo 
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prepared was determined by
 1
H NMR spectroscopy (JNM-EX, JEOL, Ltd., Tokyo, Japan). 
 
2.3. Synthesis of gelatin grafted with LAo 
The pI5 gelatin was dissolved in anhydrous dimethyl sulfoxide (DMSO, 30 ml) at room 
temperature. Various amounts of LAo with number-averaged molecular weights of 950, 2,200, and 
3,200 (1.0, 3.0, and 5.0×10
−5
 mole) were dissolved in 10 ml DMSO, and then DSC and DMAP (1.0, 
3.0, and 5.0×10
−5
 mole) were dissolved in 2.5 ml of DMSO. The solution was mixed for 3 hr under 
stirring at room temperature to activate the hydroxyl groups of LAo. The solution of activated LAo 
was slowly added to the gelatin solution, while the mixture was stirred overnight at room 
temperature for LAo grafting to gelatin. The product solution was dialyzed against double distilled 
water (DDW) with a dialysis tube with the cut-off molecular weight of 12,000–14,000 (UC 
30-32-100, EIDIA Co., Ltd, Tokyo, Japan) for 72 hr at room temperature, followed by freeze-drying 
to obtain the LAo-grafted gelatin. 
 
2.4. Measurement of critical micellar concentration of LAo-grafted gelatin 
The critical micellar concentration (CMC) of LAo-grafted gelatin was determined by the 
conventional fluorescence technique with pyrene [23]. LAo-grafted gelatin was dissolved in 10 mM 
of phosphate-buffered solution (PBS, pH 7.4) at the concentrations from 0.001 to 1 mg/ml. Pyrene 
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was dissolved in acetone at 6 mM. After mixing with the pyrene solution, change in the emission 
intensity ratio (I339/I333) of mixed pyrene and polymer solution was measured at excitation 
wavelengths of 333 and 339 nm and the emission wavelength of 390 nm. The CMC was determined 
as the concentration where the intensity ratio was sharply changed on the ratio-polymer 
concentration plot. Experiments were done independently 3 times for each sample unless otherwise 
mentioned. 
 
2.5. Dynamic light scattering measurement of LAo-grafted gelatin micelles and SEW-micelles 
To measure the apparent molecular size of LAo-grafted gelatin micelles, dynamic light scattering 
(DLS) measurement was carried out on a DLS-DPA-60HD (Otsuka Electronic Co., Ltd, Osaka, 
Japan) equipped with a He–Ne laser at a detection angle of 90° at room temperature. Each sample 
was dissolved in DDW (1.0 mg/ml). 
 
2.6. Water-solubilization of SEW by LAo-grafted gelatin 
LAo-grafted gelatin solution (1.0 mg/ml) in DDW and SEW solution (1.0 mg/ml) in ethanol were 
prepared. The SEW solution (474 μl) was added to the LAo-grafted gelatin solution (9.0 ml), 
followed by 24 hr stirring at room temperature. The reaction mixture was centrifuged (8,000 rpm, 5 
min, 4 °C) to separate water-insoluble SEW, and freeze-dried to obtain the SEW water-solubilized 
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by LAo-grafted gelatin micelles (SEW–micelles). To measure the amount of SEW incorporated into 
the SEW–micelles, acetonitrile was added to the SEW–micelle freeze-dried, followed by 
ultrasonication for 10 sec on ice to allow SEW to extract in acetonitrile. After centrifugation (10,000 
rpm, 5 min, 4 °C), the amount of SEW in the supernatant was detected by high-performance liquid 
chromatography (HPLC, LC-20AT (Shimadzu Corp., Kyoto, Japan) and TSKgel ODS-100V 5μm 
(15 cm×4.6 mm) column (TOSOH Corp., Tokyo, JAPAN). The mobile solution was a mixed of 
water–acetonitrile (10:90, v/v) solution and the flow rate was 1.0 ml/min, while the absorbance of 
SEW was measured at the wavelength of 242 nm. 
 
2.7. Preparation of gelatin hydrogels incorporating SEW–micelles 
Hydrogels were prepared through the dehydrothermal crosslinking of gelatin together with 
SEW-micelles at 160 °C for 24 hr [24]. Briefly, pI9 gelatin in DDW (100 mg/ml, 1.0 ml) and 
SEW-micelles containing 7.5 or 75 μg/ml of SEW in DDW (1.0 ml) were mixed. Then, the solution 
(2.0 ml) was cast into a polypropylene dish (20 mm×20 mm, Sakura Finetek Japan Co., Ltd, Tokyo, 
Japan), followed by freezing in liquid nitrogen and freeze-drying. The hydrogels freeze-dried were 
treated under vacuum, followed by heating at 160 °C for 24 hr. 
 




The in vitro test was performed in PBS at 37 °C for the initial 24 hr, and thereafter in PBS 
containing collagenase until to 40 hr. The sampling times were 1, 2, 4, 8, 24, 25, 26, 28, 32, 36, and 
40 hr. The gelatin hydrogel (5.0-5.5 mg) incorporating SEW-micelles containing about 3.8 μg/ml of 
SEW was placed in 500 l PBS for the initial 24 hr, followed by the sampling to collect the 
supernatant at different time intervals, and fresh 500 l PBS was added. The PBS (500 l) was 
exchanged to 500 l PBS containing 50 μg/ml collagenase, and then the similar release test was 
continued. The amount of SEW was measured by HPLC described above. For the in vitro 
degradation test, the PBS with or without collagenase was used by same way, and the sampling time 
was also same. The protein amount of supernatant sampled was determined by the micro bicinchonic 
acid (BCA) protein assay kit (Pierce, Rockford, IL, USA) to evaluate the time course of hydrogel 
degradation.  
 
2.9. In vivo test of SEW release from gelatin hydrogels incorporating SEW-micelles 
C57BL/6CrSlc male mice (8-12 weeks old) were purchased from Shimizu Laboratory Supplies 
Co., Kyoto, Japan. All the animal experimentation was conducted in accordance with the guidance of 
the Institute for Frontier Medical Sciences, Kyoto University. For the in vivo release study, the 
hydrogel was implanted into the back subcutis of mice according to the method reported previously 
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[25]. Briefly, the back skin hair of mice was shaved by a razor under pentobarbital anesthesia (50 
mg/kg). Then, the back skin was cut by a scissor and from the cut, the hydrogel (8 x 8x 2 mm
3
, 
15-16 mg) incorporating SEW-micelles containing 12 μg of SEW was implanted into the back 
subcutis, and thereafter the back skin was sutured. At 1, 3, 7, 10, 14, and 21 days after hydrogel 
application, mice were sacrificed by the over-dose injection of anesthetic, and then the hydrogels 
were taken out to measure the SEW remaining by the HPLC measurement described above. The 
experiment was independently performed for 3 samples per experimental group at each sampling 
point. 
 
2.10. In vitro migration assay 
To evaluate the bioactivity of SEW for macrophage migration, mouse bone marrow-derived 
macrophage was used [26]. Briefly, the mouse bone marrow was collected from the femurs and tibia 
of mice by the conventional syringe aspiration method. The cells collected were resuspended in 10 
ml of Iscove's Modified Dulbecco's Medium (IMDM) containing 20 vol% fetal calf serum (FCS) 
and 50 ng/ml recombinant human macrophage-colony stimulating factor (M-CSF), and cultured on 
10-cm diameter dishes in 37°C, 5% CO2-95% air atmosphere for 6 days. The cells cultured were 
used as mouse bone marrow derived macrophage. The migration of macrophage was evaluated by 
the conventional method with a modified Boyden chamber equipped with a polycarbonate filter (5 
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μm pores; Corning, NY, USA) [6]. Briefly, cells (5×10
4
 cells/well) were added to the upper 
compartment, while the lower chamber was filled with FCS-free culture medium containing 
different amounts of free SEW and different SEW amount of SEW-micelles released from the 
hydrogels. For free SEW, SEW solution (1.0 mg/ml) in ethanol was added into the medium to give 
different amounts. Cells were allowed to migrate for 3 hr, at 37 °C, and then the non-migrating cells 
present on the top of filter were removed mechanically. The migrated cells on the bottom of filter 
were fixed, and stained with Hemacolor ® (Merck Millipore, Darmstadt, Germany), to count the 
number of cells migrated for 12 areas of filter, randomly selected. 
 
2.11. Evaluation of macrophage recruitment by hydrogels incorporating SEW-micelles in the 
subcutis of mice 
Mice were anaesthetized by the intraperitoneal administration of pentobarbital (50 mg/kg). The 
hydrogels incorporating SEW–micelles containing 1 (SEW1Gel) and 10 μg (SEW10Gel) of SEW 
were implanted into the back subcutis of mice. The control samples used were SEW-free gelatin 
hydrogels, ethanol solution of 10 μg SEW, SEW-micelles containing 10 g of SEW, (SEW10 
μg-micelles solution), and PBS alone. At different time intervals, the tissue around the hydrogel 
implanted and the hydrogel were collected and digested in 2 mg/ml of collagenase D at 37°C for 1.5 
hr, followed by the collection of cell fractions through at 40 m-aperture strainers (BD Biosciences, 
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San Jose, California). The tissues and hydrogels were separated manually by before collection 
through the 40 m-aperture strainers. The cell suspensions obtained were lysed in 500 μl of lysis 
buffer (555899, BD Biosciences, San Jose, California) for 15 min at 37°C. After washing twice by 
500 μl of PBS, the cells were treated by fluorescent-labeled FITC 7-AAD (BD Biosciences, San Jose, 
California), CD45 (eBioscience, Inc., San Diego, California), Ly6G (eBioscience, Inc., San Diego, 
California), and CD11b (BD Biosciences, San Jose, California), F4/80 antibodies (Biolegend, Inc., 
San Diego, California). The cells labeled were analyzed by flow cytometry (FACSCanto II flow 
cytometer, BD Biosciences, San Jose, California). The cells with CD45+ Ly6G- CD11b+, and 
F4/80+ were defined as macrophage. The number of animals used for each experimental time point 
were 3.  
 
2.12. Evaluation of macrophage recruitment with a mouse model of skin wound 
To evaluate macrophage recruitment to the inflammatory site, a mouse model of skin wound was 
prepared [27]. Mice were anaesthetized by the intraperitoneal administration of pentobarbital (50 
mg/kg). The back hair of mice was shaved. The skin defect was made on the back subcutis by 8 
mm-size biopsy punch. The gelatin hydrogel (8 x 8x 2 mm
3
, 15-16 mg) alone (Gel) and SEW10Gel 
were applied and sutured to the surrounding skin. SEW 10mg-micelles solution was applied to the 
defect, while the defect was not covered by Gel. At different time intervals, the tissue around wound 
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area and hydrogel implanted were collected and digested in 2 mg/ml of collagenase D at 37°C for 
1.5 hr, followed by the collection of cell fractions through at 40 m strainers (BD Biosciences, San 
Jose, California). The cells were treated with FITC-labeled antibodies and analyzed by the flow 
cytometry procedure described above. 
 
2.13 Statistical analysis 
All the results were expressed as the mean ± standard deviation (SD). Significant analysis was done 





3.1. Characterization of LAo-grafted gelatin 
Table 1 summarizes the physicochemical properties of LAo-grafted gelatin prepared in different 
conditions. Every LAo-grafted gelatin showed a CMC value, which indicates property of micelles 
formation. The apparent molecular size LAo-grafted gelatin micelles ranged from 142 to 379 nm. 
The water-solubility of LAo-grafted gelatin tended to become smaller with an increase in the 
molecular weight of LAo grafted and the grafted ratio (data not shown). 
 
3.2. Water-solubilization of SEW by LAo-grafted gelatin 
Figure 1 shows the percentage of SEW water-solubilized by LAo-grafted gelatin. The amount of 
SEW water-solubilized depended on the molecular weight of LAo grafted and the grafted ratio. 
Based on the results, the LAo2-1 of LAo-grafted gelatin was used for the following experiments. 
 
3.3. SEW release from gelatin hydrogels incorporating SEW–micelles and hydrogel degradation 
Figure 2 shows the time profiles of hydrogel degradation and SEW release from gelatin hydrogels 
incorporating SEW–micelles in PBS with or without collagenase. In the presence of collagenase, 
SEW was released with time from the gelatin hydrogels. On the contrary, only 4 % of SEW release 
was observed in collagenase-free PBS (Figure 2A). In PBS containing collagenase, the hydrogels 
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were degraded with time, whereas little hydrogel degradation was observed in PBS (Figure 2B). A 
good correlation in the time profiles was observed between the SEW release and hydrogel 
degradation. Figure 3 shows the SEW was released gradually from the hydrogels incorporating 
SEW-micelles in vivo. 
 
3.4. Biological activity of SEW and SEW-micelles released from gelatin hydrogels in vitro 
Figures 4(A) and (B) shows the macrophage migration by different amounts of free SEW and 
different amounts of SEW released from hydrogels incorporating SEW-micelles for 2 and 16 hr 
incubation in PBS containing collagenase. The percentage of migrated cells in the FCS-free culture 
medium without SEW was 2.0 %. On the contrary, significantly enhanced macrophage migration 
was observed at 0.1 or higher concentrations of SEW. The SEW released from the hydrogels also 
enhanced the macrophage migration, irrespective of the SEW amount incorporated and the time 
period released.  
 
3.5 Biological activity of SEW and gelatin hydrogels incorporating SEW-micelles 
Figure 5(A) shows the macrophage recruitment 12 and 24 hr after implantation of gelatin 
hydrogels incorporating SEW-micelles. The total number of cells migrated into the sponges was 
about 1.4 and 2.1 x10
4
 cells 12 and 24 hr after treatment, respectively. Significant enhancement of 
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macrophage recruitment was detected for both the SEW1Gel and SEW10Gel. On the contrary, no 
recruitment enhancement was observed for the SEW-free gelatin hydrogels.  
Figure 5(B) shows the macrophage recruitment 12 and 24 hr after implantation of gelatin 
hydrogels incorporating SEW-micelle. The total number of cells and the tissue collected was 5.4 and 
5.8 x 10
3
 cells for 12 and 24 hr after treatment, respectively. An enhanced recruitment was observed 
for the hydrogels incorporating SEW-micelles. Macrophage recruitment was not enhanced for the 
Gel, SEW10 μg solution, and SEW10 g-micelles solution.  
Figures 6 and 7 show the time courses of the number ratio of macrophage/total cells infiltrated into 
the tissue around hydrogels at the normal tissues and the skin wound. For the normal tissue, 
significant enhancement of macrophage recruitment was observed at the tissue around the 
SEW10Gel implanted 12 hr later. On the other hand, when the SEW10Gel were implanted into the 
skin wound, macrophage was recruited into the tissue around the hydrogels 1 day after implantation 




The present study demonstrates that the biodegradable hydrogel can release the water-insoluble 
SEW of biological activity. SEW was water-solubilized by the micelles formation with LAo-grafted 
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gelatin with a CMC value. The percent water-solubilized was changed by altering the molecular 
weight of LAo grafted and the grafted ratio. It is likely that the difference in the molecular weight of 
LAo and the grafted ratio causes the different interaction of LAo components and SEW, resulting in 
varied SEW incorporation into the micelles. The micelles stabilization and the amount of SEW 
solubilized in water are influenced by the hydrophilic-hydrophobic balance of LAo-gelatin and the 
interaction between the SEW and LAo-hydrophobic core. LAo2-1 may form the micelle with the 
inner environment of an appropriate hydrophobicity which can entrap SEW. Since gelatin hydrogels 
are not degraded in collagenase-free PBS, SEW is not released from the hydrogels (Figure 2). 
Gelatin is normally degraded by enzymes, but not by a simple hydrolysis. In the presence of 
collagenase, the hydrogels would be degraded enzymatically to generate water-soluble gelatin 
fragments, resulting in SEW release due to the water solubilization of SEW associated with the 
gelatin fragment. A good correlation in the time profile between the SEW release and the hydrogel 
degradation was observed. In the hydrogel system, the SEW is released from the hydrogel only if the 
hydrogel is degraded to generate water-soluble gelatin fragments. However, a certain amount of 
SEW is initially released because SEW-micelles immobilized with non-crosslinked, free gelatin 
molecules are released out by the simple diffusion. Most of SEW-micelles immobilized with gelatin 
molecules crosslinked are released out of hydrogel as a result of gelatin water-solubilization due to 
the hydrogel degradation. This is the mechanism of SEW-micelles release from the hydrogel. In the 
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collagenase-free PBS, the gelatin hydrogel is not enzymatically degraded. In the release test in 
collagenase-containing PBS the gelatin hydrogel is degraded with time while the SEW-micelles are 
released accompanied with the degradation. The rates of SEW release evaluated from the in 
vitro release study were in good accordance with those of hydrogel degradation. This 
finding indicates that the SEW release is governed only by the degradation of hydrogels as the 
release carrier. The hydrogels achieved the controlled release of SEW even in vivo (Figure 3). It is 
likely that the SEW release in vivo was achieved through the enzymatic degradation of gelatin 
hydrogels similarly to the in vitro condition of collagenase-containing PBS. 
SEW and the SEW released from the hydrogels enhanced the in vitro macrophage migration 
(Figures 4(A) and (B)). This indicates that the activity of SEW remains even after the 
dehydrothermal treatment for hydrogel preparation, and the SEW released in the SEW-micelles form 
was also bioactive. The HPLC study revealed that the SEW released showed a peak similar to that of 
original SEW in terms of the peak position and shape (data not shown). 
The hydrogels incorporating SEW–micelles showed significant enhancement of macrophage 
recruitment in vivo, whereas the SEW-free hydrogels and SEW-micelle solution did not (Figures 
5(A) and (B)). Considering the in vivo profile of SEW release, it is conceivable that the 
concentration gradient of SEW in the tissue formed by the release plays an important role in the 
enhancement of macrophage recruitment. The significant enhancement of macrophage recruitment 
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was observed for both the normal and wound skins, although the time profiles of macrophage 
recruitment was different (Figures 6 and 7). The macrophage recruitment would be influenced by the 
tissue inflammation other than the SEW released. This is because macrophage is generally recruited 
and play a critical role in the early stage of inflammation [2].  
To evaluate the effect of SEW release profile on the in vivo macrophage recruitment, different 
types of gelatin hydrogels with different time periods of SEW release for 3, 9 or 21 days, were 
prepared, and the effect on the macrophage recruitment was assessed (Figure S2). As the result, the 
enhancement of macrophage recruitment was observed only for the hydrogels incorporating 
SEW-micelles for 21 days release. This may be explained in terms of difference in the SEW release 
profiles. An initial burst in SEW release from hydrogels releasing SEW for 3 and 9 days was large 
compared with those releasing SEW for 21 days. If the initial burst is too large and the drug is 
localized around the hydrogel only for a short time period, the concentration of SEW near the 
hydrogel will become rapidly low. It is possible that the rapid lowering SEW concentration results in 
reduced microphages recruitment. Histological evaluation was performed by the H&E and 
immunohistochemical staining methods. Unfortunately, however, the difference in the macrophage 
recruitment among the groups was not always demonstrated by the histological evaluation (data not 
shown). As the crosslinking extent of the hydrogels increases, the time period of SEW release tended 
to be longer in the back subcutis of mice (Figure S1). It is highly conceivable that the longer in vivo 
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release of SEW generates the large gradient of SEW concentration around the hydrogel, resulting in 
the enhanced macrophage recruitment in vivo.  
In conclusion, SEW was water-solubilized by the micelles of LAo-grafted gelatin. The SEW 
water-solubilized was released from the gelatin hydrogels. In vivo macrophage recruitment was 
enhanced by the controlled release of SEW from the gelatin hydrogels. The SEW concentration and 
the concentration gradient to increase the macrophage recruitment suitable for the therapeutic effects 
are not clear at present. Further study is needed to evaluate the effect of macrophage recruitment and 
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Figure 1. Percentage of SEW water-solubilized by various LAo-gelatin samples. 
 
Figure 2. The time profiles of gelatin hydrogels incorporating SEW micelles degradation (A) and 
SEW release from the hydrogels incorporating SEW micelles (B). The release test was performed at 
37 °C in PBS for the initial 24 hr, and thereafter in PBS containing collagenase. 
 
Figure 3. The time profile of in vivo SEW release from gelatin hydrogels incorporating SEW 
micelles in the back subcutis of mice. 
 
Figure 4. Macrophage migration of SEW and that released from hydrogels incorporating 
SEW-micelles. (A) The effect of SEW concentration on the number of macrophage migrated. (B) 
SEW released from hydrogels incorporating SEW-micelles for 2 and 16 hr in PBS containing 
collagenase. The concentration of SEW released was adjusted at 0.1 and 1 M based on the HPLC 
measurement. The number of macrophage migration is defined as 1 to calculate the migration ratio 
for samples. *p < 0.05; significant against the value at the SEW concentration of 0.  
 
Figure 5. (A) The number ratio of macrophage/total cells recruited into the hydrogels incorporating 1 
and 10 g of SEW or SEW-free hydrogels 12 hr (□) and 24 hr after implantation (■): SEW-free 
 28 
 
hydrogels (Gel), hydrogels incorporating SEW-micelles containing about 1.0 μg/ml of SEW 
(SEW1micelle) or SEW-micelles containing about 10 μg/ml of SEW (SEW10micelle). (B) The 
number ratio of macrophages/total cells recruited at the tissue treated by gelatin hydrogels 
incorporating SEW-micelle, SEW-micelle or SEW solution 12 (□) and 24 hr after implantation (■): 
SEW-free hydrogels (Gel), hydrogels incorporating 1 g (SEW1Gel) or 10 g of SEW (SEW10Gel), 
10 g of SEW-micelle (SEW10micelle), and 10 g of SEW solution (SEW solun). The number of 
macrophages migrated at the tissue 12 hr after Gel implantation is defined as 1 to calculate the 
migration ratio for samples. The number of animals used for each experimental time point were 3. *p 
< 0.05; significant against the value of Gel group at the corresponding implantation period.  
 
Figure 6. Time courses of the percent of macrophage/total cells infiltrated at the tissue around 
hydrogels incorporating 1 and 10 g of SEW or SEW-free hydrogels after implantation of Gel (○), 
SEW1Gel (△), SEW10Gel (□), and Gel+10mg SEW-micelles (●) on the subcutis of mice. *p < 0.05; 
significant against the value of Gel group at the corresponding time. 
Figure 7. Time courses of the percent of macrophage/total cells ratio infiltrated into the 
inflammatory tissue after implantation of Gel (○), SEW1Gel (△), SEW10Gel (□), and Gel+10mg 
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Table1. Preparation and characterization of Lao-grafted gelatin.   
Code LAo used for grafting CMC Apparent molecular size 
  Mn The ratio of LAo grafted  (g/ml)  (nm) 
     (mole/mole gelatin)     
LAo1-1 950 1 39.9 142.4±40.6a) 
LAo1-3 950 3 18.0 189.2±41.4 
LAo1-5 950 5 99.2 360.2±83.8 
LAo2-1 2200 1 21.4 245.7±127.8 
LAo2-3 2200 3 61.3 319.9±157.6 
LAo2-5 2200 5 31.6 215.2±128.9 
LAo3-1 3200 1 85.8 215.5±43.4 
LAo3-3 3200 3 40.8 230.6±44.8 
LAo3-5 3200 5 32.7 378.9±85.5 
a)






















Figure S1. The time profile of in vivo SEW release from gelatin hydrogels incorporating SEW 
micelles in the back subcutis of mice: The hydrogels were prepared at 160 °C for 6 (○), 12 (△), and 
































Figure S2. The number ratio of macrophage to total cells of SEW and that released from hydrogels 
incorporating SEW-micelles 24 hr after treatment: SEW-free hydrogels (0 - 21 day), hydrogels 
incorporating 1 g, and 10 g of SEW at different hydrogels’ degradation period, and 10 g of 
SEW-micelles. *p < 0.05; significant against the value at the SEW concentration of 0. 
